Study at a glance
Why are vitamin D and vitamin K studied together?
Vitamin D helps regulate calcium and the production of some proteins. Vitamin K helps certain proteins function properly. Their roles meet in bone and mineral handling, but they are different jobs.
Does improving a vitamin K blood marker prove stronger bones or healthier arteries?
No. A marker can show that a protein pathway responded without showing fewer fractures or less calcification, meaning calcium deposits in tissue. Those outcomes need separate evidence.
What did the aortic-valve trial find?
Vitamin K2 plus vitamin D improved a marker linked to vitamin K-dependent protein activity. It did not significantly slow calcium build-up in the aortic valve compared with placebo over two years.
Do the findings support the combination for everyone?
No. Some bone studies found benefits in selected osteoporosis groups, while other bone and vascular results were negative. The evidence also does not show that vitamin K makes excessive vitamin D safe.
Read the full article below ↓Vitamin D and vitamin K participate in the same broad mineral-regulatory system while performing different biochemical jobs. Vitamin D contributes to calcium absorption, endocrine calcium homeostasis and vitamin-D-responsive gene expression. Vitamin K enables gamma-carboxylation of vitamin-K-dependent proteins including osteocalcin and matrix Gla protein. This creates a genuine physiological interaction, but the clinical evidence does not support the popular simplification that vitamin D brings calcium into the body while vitamin K simply sends it to bone and away from arteries. Human trials instead show a more nuanced pattern: vitamin-K-dependent biomarkers can improve strongly, selected osteoporosis populations may gain bone benefit, and yet major bone or vascular structural outcomes can remain unchanged.
The interaction begins with different molecular functions
Vitamin D receptor signalling influences transcription in osteoblasts and contributes to osteocalcin expression. Vitamin K acts later through gamma-carboxylation, changing the functional state of osteocalcin and other vitamin-K-dependent proteins.
The mechanistic evidence is developed in Vitamin D, Vitamin K-Dependent Proteins and Calcium Handling: Full Study.
Osteocalcin demonstrates the division of labour
Active vitamin D can stimulate osteocalcin transcription in osteoblasts. Vitamin K is required for carboxylation of osteocalcin. Human osteoblast experiments show that vitamin K₂ can increase gamma-carboxyglutamate-containing osteocalcin accumulation in the extracellular matrix during active-vitamin-D exposure.
This supports complementary physiology. It does not show that either nutrient independently controls bone mineralisation or fracture risk.
Matrix Gla protein creates a related vascular mechanism
MGP is an inhibitor of inappropriate mineralisation in vascular tissues. Vitamin K-dependent carboxylation contributes to its functional state, while dp-ucMGP serves as a marker of inactive MGP and poor functional vitamin K status.
The presence of this mechanism makes combined vitamin D and vitamin K supplementation biologically plausible in vascular disease, but biological plausibility is not the same as demonstrated slowing of calcification.
Bone trials show benefit in some populations
Several randomized trials in postmenopausal osteoporosis reported larger increases in lumbar bone mineral density or reductions in undercarboxylated osteocalcin when vitamin K₂ was combined with vitamin D. A meta-analysis of eight randomized trials also found a favourable pooled effect on total BMD and undercarboxylated osteocalcin.
Those findings are described in Combined Vitamin D and Vitamin K Supplementation for Bone and Vascular Markers: Full Study.
The 2026 VITAL evidence limits generalisation
The VITAL ancillary analysis provides an important modern counterweight. Higher baseline vitamin K status was not associated with favourable two-year changes in bone density or architecture, and baseline vitamin K status did not modify the effect of vitamin D supplementation on bone mineral density.
This means the positive osteoporosis evidence cannot be generalized into the proposition that better vitamin K status makes supplemental vitamin D protect the skeleton in generally healthy adults.
Vascular trials separate protein activation from disease progression
The aortic-valve calcification trial provides perhaps the clearest example. Two years of MK-7 plus vitamin D substantially reduced dp-ucMGP, showing that the vitamin-K-dependent protein pathway responded. Yet aortic-valve calcification progression did not differ significantly from placebo.
Coronary and aortic calcification outcomes were also not significantly improved overall. A later coronary subgroup analysis suggested less progression among participants with high baseline CAC, but that subgroup result does not replace the null overall randomized finding.
Why biomarker success can coexist with structural failure
Carboxylating MGP is only one part of vascular mineral biology. Established calcification reflects phosphate exposure, kidney function, smooth-muscle-cell phenotype, inflammation, cell death, matrix changes and the history of mineral deposition. Correcting one inhibitory protein system may therefore be insufficient to reverse or materially slow an established lesion.
The same principle applies to bone. Better osteocalcin carboxylation does not guarantee a measurable change in fracture risk or BMD if other determinants dominate the skeletal system.
The interaction does not establish a universal supplement pairing
The evidence shows that vitamin D and vitamin K interact physiologically. It does not show that every person supplementing vitamin D requires vitamin K, that vitamin K prevents every adverse calcium effect, or that combined supplementation reliably improves vascular outcomes.
Requirements can also differ according to diet, medication use, kidney function, age and clinical condition. Vitamin K antagonists create a particularly different physiological context and should not be conflated with ordinary nutritional variation.
Vitamin K cannot be used as a safety valve for excessive vitamin D
No evidence reviewed here demonstrates that vitamin K neutralises vitamin-D-induced hypercalcaemia. Excessive vitamin D signalling can increase calcium exposure through mechanisms that remain dangerous regardless of whether vitamin-K-dependent proteins are adequately carboxylated.
That boundary is especially important when translating mechanistic nutrient interactions into consumer advice.
What the combined evidence establishes
The evidence supports a complementary relationship in which vitamin D contributes to calcium availability, endocrine regulation and expression of some target proteins, while vitamin K supports activation of specific calcium-binding proteins through carboxylation.
It supports meaningful changes in osteocalcin and MGP biomarkers with vitamin K intervention and supports bone benefit from combined therapy in some osteoporosis populations.
It does not establish a universal skeletal benefit, does not show that vitamin K status reveals a hidden vitamin D bone benefit in generally healthy adults, and does not show that MK-7 plus vitamin D prevents progression of established aortic-valve calcification.
The most defensible physiology-first conclusion is therefore that vitamin D and vitamin K perform complementary but non-identical functions within calcium and mineral regulation. Their interaction is biologically real, while the downstream clinical consequences remain dependent on population, tissue, baseline state and the endpoint being measured.
Scientific sources
Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. PMID: 9076586.
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials. PMID: 32219282.
Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL. PMID: 42524357.
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. PMID: 35465686.
The impact of vitamin K2 and native vitamin D supplementation on vascular calcification in pediatric patients on regular hemodialysis. A randomized controlled trial. PMID: 34845313.
Related reading
Adherence to Lifestyle Recommendations for Bone Health in Older Adults with and without Osteoporosis: Cross-Sectional Results of the OUTDOOR ACTIVE Study
The Osteoporosis Self-Assessment Tool and self-reported osteoporosis diagnosis were used to classify participants by osteoporosis status (low risk, high risk, diagnosis).
Original paper ↗Read more →An Asian viewpoint on the use of vitamin D and calcium in osteoporosis treatment: Physician and patient attitudes and beliefs
This study investigated the opinion of Asian physicians and Asian patients regarding vitamin D and calcium and patients’ use of both.
Original paper ↗Read more →Calcium supplementation during pregnancy and maternal and offspring bone health: a systematic review and meta‐analysis
We evaluated the impact of supplementary calcium with or without vitamin D during pregnancy on maternal and offspring bone mineral density (BMD) and teeth firmness of the offspring.
Original paper ↗Read more →Claudin-2 and claudin-12 form independent, complementary pores required to maintain calcium homeostasis
Significant calcium absorption across renal and intestinal epithelia occurs via the paracellular pathway.
Original paper ↗Read more →Divergent effects of sex and calcium/vitamin D supplementation on serum magnesium and markers of bone structure and function during initial military training
Serum Mg increased during IMT in females (0·06 ± 0·08 mmol/l) compared with males (: 0·02 ± 0·10 mmol/l; P < 0·001) and in those consuming Ca/vitamin D (0·05 ± 0·09 mmol/l) compared with placebo (0·001 ± 0·11 mmol/l; P = 0·015).
Original paper ↗Read more →Effect of calcium plus Vitamin-D combined with calcitriol in the treatment of patients with Type-2 diabetes and osteoporosis: A retrospective observational analysis
Clinical efficacy, adverse reactions, bone metabolism levels, and changes in bone density levels were compared between the two groups.
Original paper ↗Read more →Effects of 25(OH)VD3 on Growth Performance, Pork Quality and Calcium Deposit in Growing-Finishing Pigs
Dietary supplementation of 50 μg/kg 25(OH)VD3 increased calcium digestibility compared with the 0 μg/kg group (p < 0.05), and calcium and phosphorus digestibility increased quadratically as inclusion levels of 25(OH)VD3 increased (p < 0.05).
Original paper ↗Read more →Exploring the mediating role of calcium homeostasis in the association between diabetes mellitus, glycemic traits, and vascular and valvular calcifications: a comprehensive Mendelian randomization analysis
The interplay between diabetes mellitus (DM), glycemic traits, and vascular and valvular calcifications is intricate and multifactorial.
Original paper ↗Read more →Greater Calcium Intake is Associated with Better Bone Health Measured by Quantitative Ultrasound of the Phalanges in Pediatric Patients Treated with Anticonvulsant Drugs
We aimed to investigate and compare the effects of chronic antiepileptic therapy on bone health in pediatric patients using quantitative ultrasound of the phalanges (QUS) and controlling for potential confounding factors, particularly nutrient intake.
Original paper ↗Read more →Low Bone Mineral Density and Calcium Levels as Risks for Mortality in Patients with Self-Discontinuation of Anti-Osteoporosis Medication
This study aimed to investigate the relationship between mortality and low BMD of the femoral neck and vertebra among patients self-discontinuing anti-osteoporosis medication.
Original paper ↗Read more →Low forearm bone density as a clue to suspect primary hyperparathyroidism in postmenopausal women with osteoporosis: a retrospective study
Brief rationale: To evaluate the utility of forearm-DXA in differentiating postmenopausal osteoporosis and to explore its relationship with clinical features of PHPT.
Original paper ↗Read more →Low Magnesium Concentration Enforces Bone Calcium Deposition Irrespective of 1,25-Dihydroxyvitamin D3 Concentration
Efficient coordination between Mg2+ and vitamin D maintains adequate Ca2+ levels during lactation.
Original paper ↗Read more →Mcu regulates bone formation via mitochondrial calcium uptake and lineage allocation
The mitochondrial calcium uniporter (Mcu) mediates calcium influx into the mitochondrial matrix, playing an essential role in cellular energy metabolism and survival.
Original paper ↗Read more →Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models
However, the two models have never been compared in studies using animals maintained under similar conditions.
Original paper ↗Read more →Nutritional factors associated with femoral neck bone mineral density in children and adolescents
This study aimed to evaluate associations between dietary nutrient intakes (both macronutrients and micronutrients) and bone mineral density (BMD) in children and adolescents.
Original paper ↗Read more →Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD
8.1 (7.2 to 9.7) m/s, p = 0.047] compared to controls.
Original paper ↗Read more →The essential role of combined calcium and vitamin D supplementation in the osteoporosis scenario in italy: Expert opinion paper
An Italian multidisciplinary working group discussed the current Italian scenario of osteoporosis management during a meeting and highlighted the essential role of calcium and vitamin D supplementation in the prevention of fragility fractures.
Original paper ↗Read more →Vascular Calcification Is Associated with Fetuin-A and Cortical Bone Porosity in Stone Formers
The aim of the present study was to evaluate the prevalence of VC in stone formers (SF) and non-stone formers (NSF) and to investigate potential determinants of VC among SF, including circulating levels of Fet-A and bone microarchitecture parameters.
Original paper ↗Read more →Vitamin D and Calcium Addition during Denosumab Therapy over a Period of Four Years Significantly Improves Lumbar Bone Mineral Density in Japanese Osteoporosis Patients
This study investigated whether or not vitamin D and calcium supplementation affected bone metabolism and bone mineral density (BMD) over a period of four years of denosumab therapy in patients with primary osteoporosis.
Original paper ↗Read more →Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment
In the combination group, TRACP-5b was significantly decreased compared with the denosumab monotherapy group at 2 and 4 months (P.
Original paper ↗Read more →Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis
The aim of this 12-month retrospective study was to evaluate differences in the outcomes of denosumab alone or denosumab combined with vitamin D and calcium supplementation in patients having osteoporosis (OP) with rheumatoid arthritis (RA).
Original paper ↗Read more →Original sources
Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro
Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro.
Publication details
Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. PMID: 9076586.
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials.
Publication details
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials. PMID: 32219282.
Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL
Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
Publication details
Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL. PMID: 42524357.
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial.
Publication details
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. PMID: 35465686.
The impact of vitamin K2 and native vitamin D supplementation on vascular calcification in pediatric patients on regular hemodialysis. A randomized controlled trial
The impact of vitamin K2 and native vitamin D supplementation on vascular calcification in pediatric patients on regular hemodialysis.
Publication details
The impact of vitamin K2 and native vitamin D supplementation on vascular calcification in pediatric patients on regular hemodialysis. A randomized controlled trial. PMID: 34845313.